Skip to content
GLP-1 Savers
Menu
Ranked #234 · Watch List

Lighter You review

Semaglutide at $169 for four weeks and tirzepatide at $339 — advertised on the brand's own marketing site as "starting at $169/mo" for both, a figure the store charges twice over on one of them.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $169

Save ~87% vs brand-name

$169 every 4 weeks (thirteen charges a year)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The gap between the marketing site and the store it sells through is the whole story. Tirzepatide is advertised at "starting at $169/mo" and costs $339 for four weeks in the store and on the intake — twice the advertised figure, live on the same brand on the same day. Oral tablets are advertised at $249 and sell at $279. The low-dose line is advertised from $96 and every low-dose product sells at $179. And "/mo" on the marketing site is "per 4 week" in the store, which is thirteen charges a year rather than twelve. A third price list on the brand's peptide sub-site disagrees with both again. Semaglutide is the one figure that matches at $169, and it is billed every twenty-eight days.

How much does Lighter You cost?

The price Lighter You publishes is $169 every 4 weeks (thirteen charges a year). Tirzepatide is listed at $339 every 4 weeks — not the $169/mo the marketing site prints. We flag this one to watch: confirm the ongoing rate with Lighter You before you count on it, because a low first month can step up afterward. That works out about 87% under our ~$1,349/mo brand-name cash reference.

Semaglutide
$169 every 4 weeks (thirteen charges a year)
Tirzepatide
$339 every 4 weeks — not the $169/mo the marketing site prints
Coverage
All 50 states and D.C. claimed, contradicted in its own footer
Brand-name
Compounded only

The Value Score card

Lighter You scored on our six published factors. See the methodology.

Lowest Real Price76/100
No Teaser-Rate Bait30/100
Both Molecules98/100
Nationwide Availability72/100
Easy Cancellation82/100
Reputation74/100

Why it's a deal

  • Every figure that matters is published in the store before any intake, per product and per dose, so the discrepancies are checkable rather than hidden behind a signup
  • The catalog is broad and covers routes most desks do not: injectable semaglutide and tirzepatide, an oral dissolvable semaglutide tablet at $279, and six named low-dose products at $179 each
  • The low-dose products name the molecule on each item rather than selling an unnamed GLP-1, which is more than several sellers in this batch manage
  • Three dispensing pharmacies are named with addresses and phone numbers, and the telehealth operator is named in the consent copy the intake asks a patient to accept
  • Cancellation is stated once and precisely: seventy-two hours' notice before the billing date, with the effect falling on the following cycle

Read the fine print

  • Tirzepatide is advertised at "starting at $169/mo" and sold at $339 for four weeks. That is not a rounding difference or an old cache; both were live on the same day on the same brand
  • The oral tablet is advertised at $249 and sold at $279; the low-dose line is advertised from $96 and every low-dose product sells at $179. Three products, three gaps, all in the same direction
  • The marketing site says "/mo" and the store says "per 4 week", which is thirteen charges a year — so even the semaglutide figure that does match is about $2,197 a year rather than $2,028
  • A peptide sub-brand run by the same company prices the same side products differently again, so a third price list exists for a buyer to trip over
  • The terms say services are offered in all fifty states plus D.C. while the footer on every page says the service is not available in all fifty states, and no exclusion list is published
  • The questions promise a month-to-month membership with a thirty-day satisfaction guarantee while the refund policy says in capitals that no refund shall be issued on cancellation
  • No clinician, no medical group and no company address is published, and which of the three named pharmacies fills a given order is not stated
  • A tax-advantaged-account badge on the homepage sits against terms that decline to guarantee any payment is eligible for that treatment

The bottom line

Best for: Shoppers who will open the store and read the four-week price before trusting anything on the marketing pages, since the two disagree on almost every product. Semaglutide at $169 for four weeks and tirzepatide at $339 — advertised on the brand's own marketing site as "starting at $169/mo" for both, a figure the store charges twice over on one of them.

Ranked #234 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Lighter You, out of 417 others we track.

Shopping Lighter You against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Lighter You, and every program that undercuts or outscores it — starting with Primary Clinic (Direct GLP), the closest match on score — is ranked on the Lighter You alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Lighter You's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Lighter You's site. Not medical advice; see our disclosure.

Where Lighter You ranks

See every program ranked by price →

← Back to all deals